These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21717813)

  • 1. Insulin resistance, obesity and the metabolic syndrome.
    Barth RJ
    S D Med; 2011; Spec No():22-7. PubMed ID: 21717813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.
    D'Adamo E; Santoro N; Caprio S
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):549-63. PubMed ID: 19717004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance and obesity.
    Greenfield JR; Campbell LV
    Clin Dermatol; 2004; 22(4):289-95. PubMed ID: 15475228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome: practical guide to origins and treatment: Part I.
    Wilson PW; Grundy SM
    Circulation; 2003 Sep; 108(12):1422-4. PubMed ID: 14504251
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of metabolic syndrome in type 2 diabetes and its relationship with insulin resistance.
    Ahmed S; Ahmed SA; Ali N
    J Ayub Med Coll Abbottabad; 2010; 22(1):22-7. PubMed ID: 21409896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome - an ongoing story.
    Duvnjak L; Duvnjak M
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():19-24. PubMed ID: 20388942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
    Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
    Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of stress in the pathogenesis of the metabolic syndrome.
    Rosmond R
    Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.